A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.
We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.
We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.
Definition medical devices.
Both the Lantern® and OrthAlign Plus® platforms are now CE marked and available for sale.
As regulatory bodies like the FDA continue to update drug labeling with biomarkers, the role of high-precision medical devices will only grow
CE Marking and ARCH clinical trial data position the Liverty™ TIPS Stent Graft to expand treatment options for patients with advanced liver disease
Ellipsys Medical, Inc. today announced that the Ellipsys® Vascular Access System will once again be commercially available, with initial availability anticipated in mid-2026. The announcement
Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes
The technology is customized to each patient’s breast and tumor via 3D printing
The results were presented at Charing Cross 2026 by Dr. Andrew Holden during a session on Abdominal Aortic Aneurysm (AAA) disease management
This evolution formalizes Mopec Group's commitment to developing integrated, technology-driven solutions that enhance how pathology laboratories document, manage, and move through the diagnostic workflow
Connects scientific teams, data and workflows within a single, fully integrated digital lab management system
UK Biotech Day 2026 is designed to spark meaningful conversations, high‑impact collaboration and actionable outcomes, and offers the attendees the opportunity to explore the latest trends across therapeutic innovation, manufacturing, healthtech integration, regulatory developments and investment dynamics.
PathoQuest was built and supported by Kurma Partners and the Pasteur Institute and based on the groundbreaking work of Prof. Marc Eloit
Philips offers one of the most comprehensive image-guided therapy portfolios in the industry, providing solutions for visual guidance during minimally invasive procedures and image-guided therapy devices designed to enhance procedural efficiency and improve patient outcomes
Deal marks wealth firm’s fifth acquisition in 2025, building a comprehensive offering to address every financial need of healthcare professionals
For over 40 years, Teleflex Medical OEM has developed and supplied custom-engineered interventional catheter components and sub-assemblies, as well as surgical fibers and sutures, used across fast-growing treatment areas – including structural heart, neurovascular, electrophysiology and urology – that rely on advanced materials and precision manufacturing to improve surgical outcomes and patients’ lives.
Advanced manufacturing site will utilize cutting‑edge cell therapy technologies to help deliver the company’s portfolio of transformational medicines
The expansion is structured as a cost-share between BARDA and GE HealthCare, with BARDA providing the majority of funding
GENFIT will publish its 4Q25 revenue and cash position on February 26, 2026
The Series A round was led by family offices, trusts, and individual investors, a group with deep expertise across biotechnology, regenerative medicine, and healthcare innovation.
By Ravi Pratap Maddimsetty, co-founder and CTO of Uniqode, responsible for all technology strategy, product innovation and engineering execution
In this ever-changing healthcare landscape, prioritizing data-driven decision-making and proactively adopting advanced technologies will position health systems to achieve lasting success in 2026 and the years ahead
Laboratories face mounting pressure to modernize imaging, preserve tissue, and reduce sequencing failures as adoption continues to move at a glacial pace
With these latest clearances, Restore Robotics continues to deliver on its mission to provide hospitals and surgery centers with cost-effective, high-quality, and sustainable alternatives to purchasing new robotic instruments from original equipment manufacturers.
First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or dysfunction
“We are pleased to be able to bring Dr. Khan into our leadership team. He brings a strong blend of clinical, scientific, and strategic insight to SynerFuse® that will help us in our mission to provide relief to people afflicted with chronic low back and leg pain,” said SynerFuse® CEO and Founder Justin Zenanko.
Bioprocessing leader to drive continued commercial development and international expansion
The Supervisory Board will submit to the Annual General Meeting of Shareholders 2026 a proposal to appoint John DeFord (American, 1962) as a new member of the Supervisory Board.
Antony Watson appointed Chief Commercial Officer and David Van Ness to Chief Technology Officer
Co-funded by the EU’s Innovative Health Initiative (IHI), the Philips-coordinated research consortium will combine advanced medical imaging, robotic guidance technologies, and AI to standardize and enhance the precision of minimally invasive cancer treatments
Retrospective Analysis of Over 120,000 Echocardiographic Studies Provides Clinical Evidence of Diagnostic Accuracy for Heart Failure and Valvular Disease
The joint effort expands access to advanced cardiac imaging with the highest performance CT in Arizona for high-risk and underserved populations, including seniors, Native American communities, and lower-income residents.
Medicom notes this expansion continues Medicom’s work in supporting modern image exchange for the nation’s largest integrated health system.
Last Friday, the treatment of the first patient was successfully completed with a team from Micropos Medical present on site
This achievement reflects Mount Sinai’s commitment to exceptional patient care and places the organization in the top 2% of hospitals nationwide for overall clinical performance. Mount Sinai also earned America’s 250 Best Hospitals recognition for the seventh year in a row (2020–2026)
Anthem members will retain access to CHKD’s full continuum of pediatric services, including medical, surgical, and mental health care. The agreement supports responsible, sustainable care delivery while helping families and employers manage healthcare costs
The ceremony featured remarks from Moffitt and Speros leadership, state and local officials, and philanthropic partners, followed by tours of the outpatient and proton therapy spaces
Pilot program addresses critical evidence gap in emerging regenerative medicine treatments for 32.5 million Americans with knee osteoarthritis
Recommended employer actions include need for disruption, heightened scrutiny of vendor partners, sharper focus on preventive care and chronic condition management
For more information about ALF, visit www.liverfoundation.org. If you have any questions or concerns regarding liver disease, call the helpline at 1-800-Go-LIVER (800-465-4837) Monday through Friday from 9 a.m. to 5 p.m. ET.
The study cohort included 2,978 participants (mean age 56.8 years). The women were mostly postmenopausal, and 82% had category C breast density. Approximately 80% of participants had no family history of breast cancer, and 98% had no personal history of breast cancer.
This article provides an overview of the mechanism of action and clinical context of zanubrutinib in B-cell malignancies
Equipping these frontline workers with comprehensive first aid and CPR in Ottawa ensures that every clinic operates with a seamless, highly prepared safety protocol from the very moment a patient walks through the front door.
Creating a healthier indoor workplace is not a single project — it is an ongoing commitment to the people who spend their working hours inside your building.
Swypes is calling attention to a critical gap in healthcare hygiene: although hospitals and nursing homes enforce strict infection-control protocols, CDC figures and published research suggest mobile phones remain an overlooked risk in daily care settings, with one meta-analysis finding contamination on 84.5% of healthcare workers’ devices
